The session will explore the evolving role of autonomic neuromodulation as a complementary strategy to traditional ablation and pharmacologic therapies for complex, recurrent arrhythmias. Panelists will discuss emerging approaches, with particular focus on the potential for beneficial effects of sympathetic pathway attenuation at the level of ansa subclavia, a nerve bundle in the paravertebral sympathetic chain, highlighting its promise for reducing arrhythmia recurrence and addressing current limitations of existing therapies.
Powered by SymKardia
